These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9852568

  • 1. Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine.
    Batchelor M, Schenk JO.
    J Neurosci; 1998 Dec 15; 18(24):10304-9. PubMed ID: 9852568
    [Abstract] [Full Text] [Related]

  • 2. Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes.
    Page G, Peeters M, Najimi M, Maloteaux JM, Hermans E.
    J Neurochem; 2001 Mar 15; 76(5):1282-90. PubMed ID: 11238713
    [Abstract] [Full Text] [Related]

  • 3. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J, Mooslehner KA, Chan PM, Emson PC, Stamford JA.
    J Neurochem; 2003 May 15; 85(4):898-910. PubMed ID: 12716422
    [Abstract] [Full Text] [Related]

  • 4. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, Niznik HB.
    Synapse; 1998 Sep 15; 30(1):79-87. PubMed ID: 9704884
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL, Joyce AR, Carroll FI, Kuhar MJ.
    J Pharmacol Exp Ther; 2001 Jul 15; 298(1):129-40. PubMed ID: 11408534
    [Abstract] [Full Text] [Related]

  • 6. Lack of dopamine receptor agonists effect on striatal dopamine transporter binding sites.
    Little KY, Gorebig J, Carroll FI, Mapili J, Meador-Woodruff JH.
    Brain Res; 1996 Dec 02; 742(1-2):313-6. PubMed ID: 9117410
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
    Sasaki T, Kotera J, Omori K.
    J Neurochem; 2004 Apr 02; 89(2):474-83. PubMed ID: 15056290
    [Abstract] [Full Text] [Related]

  • 8. Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors.
    Yasunari K, Kohno M, Hasuma T, Horio T, Kano H, Yokokawa K, Minami M, Yoshikawa J.
    Arterioscler Thromb Vasc Biol; 1997 Nov 02; 17(11):3164-73. PubMed ID: 9409307
    [Abstract] [Full Text] [Related]

  • 9. The up-regulation of the striatal dopamine transporter's activity by cAMP is PKA-, CaMK II- and phosphatase-dependent.
    Page G, Barc-Pain S, Pontcharraud R, Cante A, Piriou A, Barrier L.
    Neurochem Int; 2004 Oct 02; 45(5):627-32. PubMed ID: 15234104
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.
    Vaughan RA, Huff RA, Uhl GR, Kuhar MJ.
    J Biol Chem; 1997 Jun 13; 272(24):15541-6. PubMed ID: 9182590
    [Abstract] [Full Text] [Related]

  • 11. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
    Morón JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM, Lin ZC, Wang JB, Javitch JA, Galli A, Shippenberg TS.
    J Neurosci; 2003 Sep 17; 23(24):8480-8. PubMed ID: 13679416
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum.
    Lindgren N, Xu ZQ, Herrera-Marschitz M, Haycock J, Hökfelt T, Fisone G.
    Eur J Neurosci; 2001 Feb 17; 13(4):773-80. PubMed ID: 11207812
    [Abstract] [Full Text] [Related]

  • 13. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
    Volz TJ, Schenk JO.
    Synapse; 2004 Dec 01; 54(3):173-82. PubMed ID: 15452864
    [Abstract] [Full Text] [Related]

  • 14. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI.
    J Comp Neurol; 1997 Nov 17; 388(2):211-27. PubMed ID: 9368838
    [Abstract] [Full Text] [Related]

  • 15. Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes.
    Cowell RM, Kantor L, Hewlett GH, Frey KA, Gnegy ME.
    Eur J Pharmacol; 2000 Feb 11; 389(1):59-65. PubMed ID: 10686296
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein.
    Chang MY, Lee SH, Kim JH, Lee KH, Kim YS, Son H, Lee YS.
    J Neurochem; 2001 May 11; 77(3):754-61. PubMed ID: 11331404
    [Abstract] [Full Text] [Related]

  • 17. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.
    Ghisi V, Ramsey AJ, Masri B, Gainetdinov RR, Caron MG, Salahpour A.
    Cell Signal; 2009 Jan 11; 21(1):87-94. PubMed ID: 18929645
    [Abstract] [Full Text] [Related]

  • 18. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
    Sandoval V, Riddle EL, Ugarte YV, Hanson GR, Fleckenstein AE.
    J Neurosci; 2001 Feb 15; 21(4):1413-9. PubMed ID: 11160413
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S.
    J Neurochem; 2004 Sep 15; 90(5):1117-31. PubMed ID: 15312167
    [Abstract] [Full Text] [Related]

  • 20. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C.
    Derbez AE, Mody RM, Werling LL.
    J Pharmacol Exp Ther; 2002 Apr 15; 301(1):306-14. PubMed ID: 11907188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.